the cell line was cloned with the fluorescence-activated cell sorter (FACS, Becton, Dickinson FACS Systems, Mountain View, Calif.). Cells were routinely maintained in stationary flasks at 37°C in RPMI-1640 medium (Irvine Scientific, Santa Ana, Calif.) that contained 15% fetal calf serum (FCS), 1 mM sodium pyruvate, 50 U/ml penicillin, and 50/~g/ml streptomycin in a humidified 7% CO2 in air atmosphere.
Biosynthetic Radiolabeling. Immunoglobulin derived from 2PK3 cells was radiolabeled biosynthetically by incubating the cells in lysine-and arginine-free RPMI-1640 medium that contained 10 #Ci/ml of both [14C]lysine and [14C]arginine (New England Nuclear, Boston, Mass.) and 10% FCS. Cells also were labeled biosynthetically with 20/~Ci/ml of [35S]methionine (Amersham Corp., Arlington Heights, Ill.) in methionine-free medium. Initial cell densities for isotope incorporation were 1-2 × 106 cells/ml and incorporation times were 16-24 h at 37°C in a humidified 7% CO2 in air atmosphere. Supernates from biosynthetically labeled cultures were used for analysis of secreted IgG. Cell extracts were used for analysis of cellular IgG. Extracts were prepared by washing 2-4 × 10 o radiolabeled cells twice in serum-free medium and solubilizing the cell pellet in 1 ml of 0.5% Nonidet P-40 (NP-40; Particle Data, Inc., Elmhurst, Ill.) in 50 mM Tris-HC1, 0.15 M NaCI, 5 mM EDTA, 0.02% sodium azide, and 50 mM phenylmethylsulphonylfluoride, pH 8.0. Solubilizatiion was for 20 min on ice with occasional vortexing, followed by centrifugation for 10 min at 12,000 g. Cell extracts and supernates were stored at -70°C.
Cell Surface Radioiodination. Ceil suspensions with viabilities >95% were surface-labeled by the lactoperoxidase method. 2 mCi of Na[125I] (Amersham Corp.) were used to label 5-10 x 107 cells in 100-200/d of mouse-tonicity phosphate-buffered saline (PBS), pH 7.3 (7.7 g NaC1, 0.54 g KH2PO4, and 2.27 g Na2HPO4 per liter). 10 ~g of lactoperoxidase (Calbiochem-Behring Corp., American Hoechst Corp., San Diego, Calif.) in 50/~1 of PBS were added to the cell suspension followed by four 10-/d pulses of H202 at increasing concentrations (0.001%, 0.003%, 0.01%, and 0.03% in PBS) at 2-min intervals. 2 min after the last pulse, the cells were washed twice in 5 ml of PBS and solubilized as described.
Immunoprecipitation. Heat-killed and formalin-fixed Staphylococcus aureus Cowan I strain (SAC) organisms (The Enzyme Center, Boston, Mass.) were used for direct and indirect immunoprecipitations (21) of cell extracts and culture supernates. Because the protein A coat protein of S. aureus binds mouse IgG2a (22) , SaC was used to directly precipitate 2PK3 IgG2a immunoglobulin.
For indirect immunoprecipitation with hybridoma antibodies (see below), it was necessary to precoat the SaC with these antibodies, saturating all protein-A-binding sites. All the antibodies used were IgG2~ proteins. 1 mg of purified antibody incubated with 50/~1 of a 10% suspension of SaC for 20 min on ice was sufficient for saturation. Excess antibody was removed by washing the coated SaC three times in a high-sah-NP-40 wash buffer (0.5% NP-40, 50 mM Tris-HCl, 0.45 M NaC1, and 0.02% NAN3, pH 8.3). To minimize nonspecific binding of labeled proteins to SaC, extracts and supernates were precleared with GPCo8 (Igh-la) myeloma proteinsaturated SaC. 1 ml of cell extract (representing 2 × 106 cells) or 2 m[ of culture supernate was precleared with 20-50/LI of GPC-8-coated SaC, followed by centrifugation for 10 min at 1,500 g. All immunoprecipitates were washed with high-sah-NP-40 wash buffer (see above) that contained 2 mM lysine, 2 mM arginine, 2 mM methionine, and 5 mM KI before gel analysis. Labeled proteins were eluted from the SaC with isoelectrofocusing sample buffer. (23) .
Polyacrylamide Gel Electrophoresis. The two-dimensional polyacrylamide gel system utilizing nonequilibrium pH-gradient electrophoresis for the first dimension and 10% sodium dodecyl sulfate (SDS)-polyacrylamide gel eleetrophoresis for the second dimension has been described previously (24) (25) (26) . One-dimensional SDS-polyacrylamide slab gels are identical to the second dimension of the two-dimensional system. Autoradiography of gels was from 1-3 d. Gels with 14C-and 35S-labeled proteins were exposed to Kodak No-screen film (Eastman Kodak Co., Rochester, N. Y.) at room temperature; and gels with 125I-labeled proteins were exposed to Kodak X-omat R film at -70°C with DuPoint Cronex Lighming-Plus intensifying screens (DuPont Instruments, Wilmington, Del.).
Inhibition of Glycosylation. Tunicamycin blocks the formation of the dolichol pyrophosphate
intermediate that mediates core oligosaccharide addition to specific asparagine residues of nascent polypeptide chains (27, 28) . Because IgG heavy chains have a single N-acetylglucosaminyl-asparagine-linked oligosaccharide (29) , glycosylation of IgG2a heavy chains can be inhibited effectively with tunicamycin (30) . Inhibition of glycosylation was with 5/Lg/ml of Hybridoma Antibodies. Monoclonal hybridoma anti-Igh-la antibodies were generated and prepared as described previously (26, 34, 35) . The seven antibodies used in this study are listed in Table I . Inc., Miles Research Products) was as described previously (34) . Fig. 5 is a schematic diagram of the heavy chain domain composition of these fragments. These fragments were labeled with Na[a25I] using 1,3,4,6-tetrachloro-3a,6a-diphenylglyoluril (Iodogen, Pierce Chemical Co., Rockford, Ill.) as described (34, 36) . Immunoprecipitation of labeled fragments with hybridoma antibodies was carried out using a solid-phase plate-binding procedure. Hybridoma antibodies (30 #1) were coated onto the well bottoms of flexible plastic 96-well plates (Cooke Laboratory Products, Division of Dynatech Laboratories, Alexandria, Va.) at 50 #g/ml in 50 mM Tris-HCI, 0.15 M NaCI, pH 8.1, that contained 50 #g/ml bovine serum albumin (BSA) for 1 h at room temperature. Excess reagent was removed and the free protein-binding sites in the wells were saturated by washing the plate with 1% BSA in PBS. Radioiodinated fragments in 30 #1 were then added to the solid-phase antibodies for 1 h at room temperature. Excess label was removed by washing again with 1% BSA in PBS. Labeled fragments specifically bound to the plates were eluted with SDS-sample buffer for gel analysis (23) .
Results
Membrane 2PK3 Immunoglobulin Is Larger and More Acidic Than Its Secreted Homologue. The immunoglobulin heavy chain precipitated from surface-iodinated 2PK3 cells with SaC or with SaC coated with hybridoma antibody Ig(la) 14.4 is larger and more acidic than the biosynthetically labeled heavy chain secreted into the culture supernate of 2PK3 cells ( Fig. 1) . Fig. 1 A shows the heavy and light chains of secreted IgG precipitated from culture supernate of 2PK3 cells grown under biosynthetic labeling conditions. The line of related spots obtained from this monoclonally derived immunoglobulin heavy chain probably result from the deamination of the polypeptide chain. Similar modification of the 2PK3 light chain is less apparent. Fig. 1 B shows the membrane heavy and light chains precipitated from surfaceiodinated 2PK3 cells. The major heavy chain spots have a higher Mr and are more acidic than the secreted heavy chain. A trace of material is seen where the secreted IgG is found in Fig. 1 A. This may represent IgGjust being secreted or precursor IgG from dead cells present in the cell preparation used for radioiodination. The membrane heavy chain has an Mr of ~65,000, whereas the secreted chain has an Mr of -55,000. Both Fig. 1 A and B show identical light chain spots. Fig. 1 C shows that both immunoglobulin molecules described above are precipitated from extracts of biosynthetically labeled 2PK3 cells. The higher molecular weight chain is in the identical position as the surface-iodinated membrane heavy chain. The lower molecular weight heavy chain, which migrated to the same position as the secreted IgG found in culture supernate, probably represents the cellular precursor to secreted IgG.
The Apparent Molecular Weight Difference between Membrane and Secreted IgG Is Not a Result of Different N-Glycosidic-linked Oligosaccharide Chains. Studies with tunicamycin
and endoglycosidase H show that the difference between membrane and secreted 2PK3 IgG is not a result of different asparagine-linked glycosylation of a single heavy chain precursor. Tunicamycin selectively inhibits asparagine-linked IgG heavy chain glycosylation (30) . Fig. 2 shows that after tunicamycin treatment, both membrane and secretory heavy chain from labeled 2PK3 extracts have lower Mr (panel B). In Fig. 2 and subsequent figures, only the heavy chain regions of the two-dimensional gels are shown. Blocking the addition of asparagine-linked oligosaccharide chains to 2PK3 immunoglobulin heavy chains does not affect the presence of the two biosynthetic molecules in 2PK3 cell extracts. Therefore, the Mr and net electrophoretic charge difference between membrane and secretory IgG is not a result of different Nglycosidic-linked oligosaccharides.
The reduction in Mr of both membrane and secreted molecules after tunicamycin treatment is about 1,000-2,000. It is interesting to note here that the preformed oligosaccharide core transferred from the dolichol pyrophosphate intermediate has an Mr of -2,000 (28) . It also should be noted, in agreement with other studies (30) , that the nonglycosylated, intracellular secretory IgG made in the presence of tunicamycin is secreted as such into the culture supernate ( Fig. 2 D) .
Two IgGza heavy chains, corresponding to the membrane and secreted molecules, also are seen after endoglycosidase H was used to remove the high mannose Nglycosidic-linked oligosaccharide core from internal IgG2a heavy chain precursors. The oligosaccharide chain of only some of the cellular 2PK3 heavy chains are susceptible to hydrolysis ( Fig. 3 ). Both secretory and membrane forms are equally affected, indicating that some of both IgG2a heavy chains have unprocessed oligosaccharide chains. This is seen as the new lower molecular weight spots in Fig. 3B (compare with Fig. 3 A) , which also are comparable to the nonglycosylated molecules seen after tunicamycin treatment (Fig. 2 ). As expected, no effect was seen with endoglycosidase H treatment of already secreted 2PK3 IgG ( Fig. 3 C and D) . Membrane IgG2a Lacks an Allotypic Determinant Present on Secreted IgG2a. Six different hybridoma anti-Igh-la antibodies precipitated secreted 2PK3 IgG2a, however, only five of these antibodies precipitated the m e m b r a n e molecule. The sixth, Ig(la) 15.3, reacted poorly, if at all with the m e m b r a n e molecule although its precipitation of secreted molecule was about equal to the other antibodies. Fig. 4 shows the gel pattern of the surface-iodinated 2PK3 cell extracts precipitated with Ig(la)14.4 (Fig. 4A) , which is typical of the five antibodies that are reactive with both IgG molecules and with Ig(la)15.3 (Fig. 4B) . The contaminating secretory-type IgG in the surfaceiodinated extract clearly is evident in both precipitates. The Ig(la)15.3 precipitate presented here shows a trace of m e m b r a n e molecule; however, in other experiments, the m e m b r a n e heavy chain is totally absent. It is important to note here that the autoradiograph of the Ig(la)15.3 precipitate shown in Fig. 4B is a 3-d exposure, whereas Fig. 4A is an autoradiograph exposed for 1 d. This experimental variation Fdc consists of Vn, Cn 1, hinge, CH2, and probably some of the CH3 domains. The S. aureus protease fragments described here are larger than was reported previously (34) . This appears to be a result of the batch of enzyme used. The location of the allotypic determinants on GPC-8 myeloma protein recognized by hybridoma antibodies Ia(la)15.3 and Ig(la)14.4, based on results presented in Fig. 6 , are shown. These results must be interpreted in view of results obtained with another Igh-la protein presented in the text.
1267 may reflect how efficiently the SaC is coated with hybridoma antibody; free protein-A sites on the SaC would bind the membrane form. Fig. 4C shows the precipitate using uncoated SaC.
The Location of the Missing Membrane Allotypic Determinant on Secreted IgGaa
Molecules. The location of the determinant recognized by each hybridoma antibody was determined by testing the reactivity of these antibodies with GPC-8 (Igh-la) myeloma protein fragments (Fig. 5 ). Both Ig(la)16.3 and Ig(la)14.4 antibodies precipitate the Fc, the (Fab')2, and (Fabc)2 fragments derived from GPC-8 ( Fig. 6 ). On the other hand, although Ig(la) 15.3 precipitates the (Fab')z and (Fabc)z fragments, it reacts poorly, if at all with the GPC-8 Fc fragment (Fig. 6 ). None of the hybridoma antibodies reacts with Fab fragments.
From these results it would appear that the allotypic determinant recognized by Ig(la)15.3 is located in or near the hinge region of GPC-8. After this paper was submitted, however, we found that Ig(la)15.3 reacts with the Fc fragment from another Igh-la protein, a hybridoma-derived protein called 29-B. 1 (34) . Both GPC-8 and 29-B.1 Fc fragments were made with the same digestion procedure and both have the same Mr when analyzed by SDS-polyacrylamide gel electrophoresis, yet the allotypic determinant on GPC-8 recognized by Ig(la) 15.3 is lost after papain digestion, whereas the 29-B. 1 Fc retains reactivity. In view of these results, a general conclusion on the location of this determinant on secreted Igh-la proteins cannot be made.
The determinant on GPC-8 is not at the carboxy-terminus of the molecule, because the (Fab')2 and (Fabc)2 fragments from GPC-8 react with Ig(la) 15.3. The intact GPC-8 hinge region either contains the determinant or somehow affects reactivity with the determinant, located elsewhere on the molecule. This could be a result of a genetic difference between the two proteins. GPC-8 was derived from a BALB/c subline maintained in Australia which has been separated from the BALB/cN subline since 
Removal of the N-Glcosidic-linked Oligosaccharide on Secreted IgG2a Does Not Affect the Expression of the Ig(la)15.3 Allotypic Determinant. We have already d e m o n s t r a t e d that
different N-glycosidic-linked oligosaccharide chains do not account for the difference in M r and electrophoretic charge between m e m b r a n e and secreted IgG2a. O u r results also demonstrate that the nonglycosylated secretory heavy chain precursor in 2PK3 cells treated with tunicamycin is precipitated with Ig(la)15.3 (gel not shown). Thus the removal of the oligosaccharide chain on secreted IgG2, does not affect the expression of the Ig(la)15.3 allotypic determinant.
Nonglycosylated Membrane IgG2,~ Heavy Chains Do Not Appear to Express Allotypic Determinants.
We are not certain whether the nonglycosylated m e m b r a n e molecule expresses the Ig(la)15.3 determinant. It is conceivable that the m e m b r a n e N-glycosidiclinked oligosaccharide masks this allotypic determinant. W e have not been able to test this possibility because it appears that nonglycosylated m e m b r a n e molecules are not precipitated with any of the h y b r i d o m a antibodies.
In untreated 2PK3 cell extracts, only a portion of the i m m u n o g l o b u l i n precipitable with SaC is precipitable with h y b r i d o m a antibodies. Cell extracts that have been exhaustively cleared of i m m u n o g l o b u l i n reactive with h y b r i d o m a antibodies still have immunoglobulin that is precipitable with SaC, This is true for m e m b r a n e and secretory molecules that are precipitable with Ig(la)14.4, which reacts with both molecules, and for secretory molecules precipitable with Ig(la)15.3 (data not shown). A possible explanation for this m a y be that the expression of some allotypic a n d / o r isotypic determinants are dependent on intracellular IgG tetramer assembly; protein A binding may not have such a prerequisite.
In tunicamycin-treated cell extracts, the reactivity of nonglycosylated secretory heavy chains with hybridoma antibodies is indistinguishable from their glycosylated homologues; however, the amount of nonglycosylated membrane heavy chain that is precipitable with Ig(la)14.4, which precipitates some of the internal glycosylated membrane heavy chain, is small, if present at all, compared with SaC precipitation. (Fig. 2 B shows the SaC precipitate of tunicamycin-treated cell extracts.) It appears that the expression of some allotypic determinants on membrane IgG2~ heavy chains and not secretory heavy chains is dependent on asparagine-linked glycosylation. We do not know the molecular basis of this result. It may be that glycosylation is important for the proper folding of the membrane heavy chain or the assembly of membrane IgG tetramer, and these processes are required for determinant expression.
One might expect that two distinct assembly pathways for membrane and secretory molecules are needed in a single cell that produces both molecules. These pathways would be dependent on structural differences (perhaps in the hinge region) between the membrane and secreted molecules. This would explain why mixed IgG2~ tetramers that consist of two light chains associated with one membrane and one secretory heavy chain have not been seen ( Fig. 2A and B) . Precedents for protein structure affecting assembly patterns have been described (37, 38) .
Discussion
We have demonstrated that membrane and secreted IgGza from a monoclonal cell line are different on the basis of Mr, net charge, and allotypic determinants. The charge and molecular-weight differences are not a result of different N-glycosidiclinked oligosaccharides, but the possibility that the membrane molecule has additional serine-and/or threonine-linked glycosylation sites has not been excluded rigorously. Such O-glycosidic-linked oligosaccharides could account for the differences between the membrane and secreted heavy chains described here; however, the presence of additional sites for oligosaccharide attachment would suggest that membrane and secreted heavy chain molecules have primary-amino-acid-sequence differences.
The allotypic determinant recognized by Ig(la)15.3 was shown not to be affected by removal of the N-glycosidic-linked oligosaccharide chain on secreted IgGza molecules. Because secreted IgG molecules are known to have a single asparagine-linked oligosaccharide chain, we are certain that the Ig(la)15.3 allotypic determinant is not this carbohydrate structure. It still is conceivable however, that the asparagine-linked oligosaccharide on membrane heavy chains is sufficiently different that it masks this allotypic determinant. There are previous indications that membrane-associated immunoglobulins appear to lack allotypic and isotypic antigenic determinants found on secreted molecules (39) (40) (41) . Some of these studies show that determinants near the carboxy terminus of the immunoglobulin apparently are inaccessible to antibody probes. The absence of the Ig(la)15.3 determinant on detergent-solubilized molecules makes this an unlikely explanation for our results.
A recent study (42) indicated that IgG isolated from mouse spleen cell extracts behaves as though it contains a hydrophobic region. Our own preliminary data from charge-shift electrophoresis (43) experiments confirm this result. This would indicate that the membrane IgG2~ heavy chain we have described is an integral membrane protein.
Membrane IgM and IgD clearly contain hydrophobic structures that could anchor them in membranes (43, 44) ; 2 however, there are no published primary amino acid sequence data demonstrating this extra hydrophobic segment. Although peptidemapping studies demonstrate that there are differences between membrane and secreted IgM heavy chains (10) , the location of these peptide differences has yet to be determined. Our data, demonstrating a missing allotypic determinant on membrane IgG, suggest that a primary structural difference occurs in the Fc part of the molecule. Taken together with the evidence that membrane IgG may have a hydrophobic sequence anchoring it in the membrane, it would appear that there may be significant structural differences between membrane and secreted IgG2a heavy chains, one within the Fc part of the molecule and the other near the carboxy-terminus (for which there is no direct evidence). This structural model would account for the molecular weight, charge, and allotypic differences between the two molecules. It also provides a structural basis for the faithful assembly of membrane and secreted tetrameric IgG molecules in the same cell.
Two other structures also could explain the differences described here. One is that the addition of a carboxy-terminal hydrophobic segment to membrane IgG2a induces a conformational change in another region of the heavy chain, accounting for the absence of the Ig(la) 15.3 allotypic determinant. The other is that a primary structural difference in the membrane molecule induces a conformational change in the carboxyterminus, exposing a hydrophobic region which then anchors the molecule in the membrane. It is conceivable that different membrane heavy chain homologues could adopt any of these structural strategies.
Structurally distinct membrane and secretory molecules of the same immunoglobulin heavy chain class could be generated in two ways: (a) there could be two distinct cistrons coding for membrane and secreted molecules; or (b) an alternate RNA splicing mechanism could yield similar but different messenger RNA (mRNA) from the same primary RNA transcript, which are translated into membrane and secreted heavy chains. From peptide mapping studies (10), it appears that the primary amino acid sequences of membrane and secreted IgM heavy chains are very similar (though not identical). Allotypic and isotypic determinants also are generally conserved between membrane and secreted molecules. If there are distinct cistrons for each molecule, w.e would expect more divergence in allotypy and isotypy between membrane and secreted products.
We feel that it is more likely that an alternate mRNA splicing mechanism generates both gene products from the same DNA sequence. Recently, the entire genomic sequence of the (secreted) IgG2b (Igh-3a) heavy chain cistron was completed (45, 46) . There is a 300 base intron separating the CH1 and hinge exons that is large enough to accomodate an additional hinge region exon. An alternate hinge exon could be either entirely in the intron or overlap the secreted hinge exon. An overlapping sequence could be read in or out of frame, resulting in shared or different Fc sequences.
Simian virus 40 (SV40) genomic expression provides an excellent precedent for such an RNA splicing mechanism (47) . Two early mRNA, arising in SV40-transformation code for two serologically and biochemically similar transformation (T) antigens. These have been shown to be derived from overlapping viral genomic DNA sequences (48, 49) . Alternate RNA splicing may be a general mechanism for synthesizing two (or more) different, but nearly identical, proteins. Recently, a third SV40 early mRNA has been described that also shares T antigen-coding sequences (50) . This mRNA represents an additional RNA splicing product that may code for the tumor-specific transplantation antigen (TSTA) found associated with membranes of SV40-transformed cells (50, 51) . TSTA is serologically indistinguishable from T antigen (51) . Examination of the SV40 genomic sequence that codes for this mRNA transcript has suggested that translation read out-of-phase at the 3' end of the viral cistron (relative to the T-antigen-coding sequence) would yield a polypeptide with a hydrophobic carboxy-terminus (50) . A similar mechanism could operate on immunoglobulin cistrons, yielding a membrane anchor for IgG heavy chains.
The difference between membrane and secreted IgG2a also could play a key functional role in T cell regulation of antibody formation. B cell differentiation and antibody production is known to be regulated by both carrier-specific and Ig-specific helper T cells (52) (53) (54) (55) (56) (57) . The molecular basis for the interaction between Ig-specific T cells and Ig-bearing B cells has been a puzzle. It has always been difficult to imagine such a recognition process occuring in the presence of secreted molecules sharing the same antigenic determinants. Some of the recognition sites must also be genetically polymorphic, because allotype-specific recognition by T cells has been observed in allotype-heterozygous mice (56, 57) . Polymorphic determinants unique to membrane immunoglobulin then might be the recognition sites by which such interactions occur.
Summary
We have demonstrated that there are structurally distinct membrane and secreted IgG~ immunoglobulin molecules. The membrane heavy chain is both larger and more acidic than the secreted molecule. This difference is not a result of different Nglycosidic-linked oligosaccharide chains. The membrane heavy chain also is antigenically different from its secreted homologue. This is based on the fact that secreted IgG2a molecules express an allotypic determinant absent on membrane molecules.
We discussed the genetic control and gene organization of membrane and secreted immunoglobulin heavy chain sequences and suggest mechanisms controlling the expression of the simian virus 40 genome as models for alternate gene expression of membrane and secreted heavy chain polypeptide chains from the same DNA sequence. The possible biological significance of the membrane immunoglobulin acting as a recognition site for regulatory T cells also is discussed. The difference between membrane and secreted immunoglobulin is proposed as a possible explanation for the manner in which T cells interact with IgG on memory B cells in the presence of a large excess of IgG present in body fluids.
